Mease P, Coates LC, Kirkham B, McLeod LD, Mpofu S, Karyekar C, Gandhi K. Secukinumab improves minimal disease activity response rates in patients with active psoriatic arthritis: data from phase 3 FUTURE-2 study. Poster presented at the 10th International Congress on Spondyloarthritides; September 2016. Gent, Belgium. Previously presented at the 2016 Annual European Congress of Rheumatology (EULAR).